A Xifaxan, Rifacol, Fatroximin, Rifaximin written confirmation (Xifaxan, Rifacol, Fatroximin, Rifaximin WC) is an official document issued by a regulatory agency to a Xifaxan, Rifacol, Fatroximin, Rifaximin manufacturer, verifying that the manufacturing facility of a Xifaxan, Rifacol, Fatroximin, Rifaximin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Xifaxan, Rifacol, Fatroximin, Rifaximin APIs or Xifaxan, Rifacol, Fatroximin, Rifaximin finished pharmaceutical products to another nation, regulatory agencies frequently require a Xifaxan, Rifacol, Fatroximin, Rifaximin WC (written confirmation) as part of the regulatory process.
click here to find a list of Xifaxan, Rifacol, Fatroximin, Rifaximin suppliers with Written Confirmation (WC) on PharmaCompass.